Pharmacokinetics and influence of arbekacin on renal function in low-birth-weight infants

Journal of Infection and Chemotherapy

Volumn 3, Issue 3, 1997, Pages 160-163

  Sakata, Hiroshi ^a   Maruyama, Shizuo ^a   Ishioka, Toru ^a   Shirai, Masaru ^a   Taketazu, Genya ^a   Nagaya, Ken ^a   Katano, Toshihide ^a  

^a Asahikawa Kosei Hospital   (Japan)

Author keywords

Arbekacin; Low birth weight infants; N acetyl D glucosaminidase; Nephrotoxicity; 2 microglobulin

Indexed keywords

EID: 0037552594     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02491507     Document Type: Article

References (14)

1. Kondo S, Iinuma K, Yamamoto H, Maeda K, Umezawa H. Syntheses of 1-N-{(S)-4-amino-2-hydoroxybutyryl}-kanamycin B and-3′4′-dideoxykanamycin B active against kanamycin resistant bacteria. J Antibiot 1973;26:410-415.
2. Inoue M, Nonoyama M, Okamoto R, Ida T. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic against methicillin-resistant Staphylococcus aureus. Drugs Exp Clin Res 1994:20;233-240.
3. Hayashi I, Inoue M, Hashimoto H. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. Drugs Exp Clin Res 1994:20;225-232.
4. Fujii R, Fujita K, Sakata Y, Abe R, Tajima T, Terashima I, et al. Clinical of arbekacin sulfate in the pediatric field. Jpn J Antibiot 1994;47:57-83.
5. Kurebe M. Yokota T, Niizato T, Kai F, Yoshida T, Okamoto R, et al. Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin. Arzneimittel-Forshung 1986;36:1511-1517.
6. Langhendries JP, Gillain N, Battisti O, Carlier B, Bertrand JM. Normal values for urinary N-acetyl-beta-glucosaminidase excretion in preterm and term babies. Arch Dis Child 1987;62:483-486.
7. Chen JY, Lee YL, Liu CB. Urinary β2-microglobulin and N-acetyl-β-D-glucosaminidase (NAG) as early markers of renal tubular dysfunction in sick neonates. J Formosan Med Assoc 1991;90:132-137.
8. Aoki Y. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. Jpn J Antibiot 1994;47:640-646.
9. Sakata H, Amamiya S, Sato T, Kajino M, Ishioka T, Maruyama S. Urinary N-acetyl-β-D-glucosaminidase activity in very-low-birth-weight infants. Acta Neonat Jpn 1995;31:254-258.
10. Gouyon JB, Aujard Y, Abisror A, Laudignon N, d'Athis P, Jacqz E, et al. Urinary excretion of N-acetyl-glucosaminidase and β-microglobulin as early markers of gentamicin and nephrotoxicity in neonates. Dev Pharmacol Ther 1987;10: 145-152.
11. Langhendries JP, Mattot M, Francois A, Deprez D, Battisti O, Bertrand JM, et al. Validity of N-acetyl-β-D-glucosaminidase (NAG) determination in assessing netilmicin nephrotoxicity in preterm babies. Biol Neonate 1989;56: 78-82.
12. Milanda JC, Shimmel MM, James LS, Spinelli W, Rosen TS. Gentamicin kinetics in the neonate. Pediatr Pharmacol 1985;5:57-61.
13. Koren G, Leeder S, Harding E, Jacques D, McLeod SM. Optimization of gentamicin therapy in very low birth weight infants. Pediatr Pharmacol 1985;5:79-87.
14. Zarowitz BJ, Wynn RJ, Buckwald S, Szefler SJ. High gentamicin trough concentration in neonates of less than 28 weeks gestational age. Dev Pharmacol Ther 1982;5:68-75.